Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • プラットフォームと自動化
  • 検出システムソリューション
  • 放射性化学物質
  • 8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, 1 mCi (37 MBq)

8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, 1 mCi (37 MBq)

NENSure radiochemical vial and container
8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, 1 mCi (37 MBq)
NENSure radiochemical vial and container
NENSure™ radiochemical vial and container
NENSure radiochemical vial and container

8-OH-DPAT radioligand tritiated at the 1,2,3 position on the propyl-2,3-ring. 8-OH-DPAT is a serotonin receptor agonist specific for the 5-HT1A and 5-HT7 receptors.

View product information
Feature Specification
Concentration 1 mCi/ml
Label Position Specifically Labeled
Molecular Weight 247.4
Receptor 5-Hydroxytryptamine

8-OH-DPAT radioligand tritiated at the 1,2,3 position on the propyl-2,3-ring. 8-OH-DPAT is a serotonin receptor agonist specific for the 5-HT1A and 5-HT7 receptors.

View product information
Product variants
Unit Size: 250 µCi
Part #:
NET929250UC
Unit Size: 1 mCi
Part #:
NET929001MC
For research use only. Not for use in diagnostic procedures.
Request more information
NENSure radiochemical vial and container
8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, 1 mCi (37 MBq)
NENSure radiochemical vial and container
NENSure™ radiochemical vial and container
8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, 1 mCi (37 MBq)
NENSure radiochemical vial and container
Quick links
  • Variants
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Get help

Product information

  • Overview
  • Specifications

Overview

1 mCi quantities of 8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, are available for research. 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) is a highly selective full agonist of the 5-HT1A receptor that also stimulates the 5-HT7 receptor and has been shown to label 5-hydroxytryptamine (5-HT) reuptake sites. These receptors are part of a group of serotonin G-protein coupled receptors (GPCRs) found in the central and peripheral nervous systems, and modulate the release of neurotransmitters and hormones. 5-HT receptors are the pharmacological target of many antidepressants, antipsychotic, anti-migraine, and other pharmaceutical drugs.

We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.

Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NET929:

  1. Vidal R., Linge R., Castillo M.J., Amigó J., Valdizán E.M., Castro E. (2016) Autoradiographic Visualization of G Protein-Coupled Receptors in Brain. In: Luján R., Ciruela F. (eds) Receptor and Ion Channel Detection in the Brain. Neuromethods, vol 110. Humana Press, New York, NY.
  2. Toshiyuki Ueki, Kazushige Mizoguchi, Takuji Yamaguchi, et al. Yokukansan Increases 5-HT1A Receptors in the Prefrontal Cortex and Enhances 5-HT1A Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice, Evidence-Based Complementary and Alternative Medicine, Volume 2015, 2015.
  3. Kiyoshi Terawaki, Yasushi Ikarashi, Kyoji Sekiguchi, Yoichiro Nakai, Yoshio Kase. Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells, In Journal of Ethnopharmacology, Volume 127, Issue 2, 2010, Pages 306-312.

Specifications

Concentration
1 mCi/ml
Molecular Weight
247.4
Specific Activity
100 - 200 Ci/mmol (3700 - 7400 GBq/mmol)
CAS Number
76135-31-4
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
Ethanol
Detection Modality
Radiometric
Label Position
Specifically Labeled
Molecular Formula
C16H25NO
Packaging
NENSure vial
Radioisotope
3H
Receptor
5-Hydroxytryptamine
Shipping Information
Shipped in dry ice
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
-80°C
Therapeutic Area
CNS & Neurologic
Unit Size
1 mCi

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Flyer:-:1
  • Guide:-:1
  • Product Info:-:1
1-1 of 1 Resources
Guide Icon
Guide
Tritium handling precautions
Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.